Money
Lupin, Aurobindo, Cipla Fall Up To 2.9%: Pharma Stocks Under Pressure As Trump's Tariff Roadmap Rattles Sentiment
Indian pharmaceutical stocks traded lower in early deals on Wednesday after US President Donald Trump unveiled a phased tariff roadmap for imported generic medicines. As of 9:30 am, most frontline pharma stocks were trad
Ni Mohammad Haris31K nabasa

Indian pharmaceutical stocks traded lower in early deals on Wednesday after US President Donald Trump unveiled a phased tariff roadmap for imported generic medicines. As of 9:30 am, most frontline pharma stocks were trading in the red. Among the major laggards, Lupin fell 2.88% to Rs 2,442.40, Aurobindo Pharma declined 2.73% to Rs 1,536.60, Alkem Laboratories slipped 2.44% to Rs 5,543, Zydus Lifesciences dropped 2.20% to Rs 1,117.90, while Cipla was down 2.09% at Rs 1,402.60.